title: Back to the future of psychopharmacology: A perspective on animal models in drug discovery.
abstract: Psychopharmacology has had some bad publicity lately. Frankly, there have been some major problems along the way in developing new effective drugs for psychiatric disorders. After a prolonged period of high investments but low success rates, big pharmaceutical companies seem to retract their activities in the psychopharmacology field. Yet, the burden of mental disorders is likely to keep on growing in the next decades. In this position paper, we focus on drug development for depression and anxiety disorders, to narrow the scope of the assay. We describe the current situation of the psychopharmacology field, and analyse some of the methods and paradigms that have brought us here, but which should perhaps change to bring us even further. In addition, some of the factors contributing to the current stagnation in psychopharmacology are discussed. Finally, we suggest a number of changes that could lead to a more rational strategy for central nervous system drug development and which may circumvent some of the pitfalls leading to "me too" approaches. Central to the suggested changes, is the notion that mental disorders do not lead to several symptoms, but a network of causally related symptoms convolutes into a mental disorder. We call upon academia to put these changes in the early phases of drug development into effect.
authors: Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: h.hendriksen@uu.nl.
authors: Hendrikus
authors: H
authors: Hendriksen
authors: Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
authors: Lucianne
authors: L
authors: Groenink
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D055808:Drug Discovery / Q000379:methods / Q000639:trends; D004353:Drug Evaluation, Preclinical; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D011600:Psychopharmacology / Q000379:methods / Q000639:trends; D011619:Psychotropic Drugs / Q000627:therapeutic use; D057170:Translational Research, Biomedical / Q000379:methods* / Q000592:standards
chemical_list: D011619:Psychotropic Drugs
keywords: Affective disorder; Animal model; Animal research; Anxiety disorders; Drug therapy; Mice; Pharmacology; Psychological primitive; Rats